The NEPHROCHECK Test System Training Program. The NEPHROCHECK Training Program US: Astute Medical, Inc PN Rev D 2014/09/16
|
|
- Dortha Perkins
- 6 years ago
- Views:
Transcription
1 The NEPHROCHECK Test System Training Program The NEPHROCHECK Training Program US: Astute Medical, Inc PN Rev D 2014/09/16
2 Learning Objectives At the conclusion of this training, participants will be able to: 1. Evaluate the importance of risk assessment for Acute Kidney Injury (AKI). 2. Identify the NEPHROCHECK Test System components. 3. Summarize how to run the NEPHROCHECK Test. 4. Interpret the NEPHROCHECK Test results in the context of the NEPHROCHECK Test s performance. 5. Recognize the NEPHROCHECK Test limitations and their implications in the use of the test. 6. Identify the components of the NEPHROCHECK Test training program and related support services. 7. Understand how to request additional training and how to access training materials. 2
3 Table of Contents I. Importance of Risk Assessment for AKI II. The NEPHROCHECK Test System III. Clinical Performance IV. Interpreting the NEPHROCHECK Test Results V. Limitations of the NEPHROCHECK Test VI. Training Program Materials and Support 3
4 I. Importance of Risk Assessment for AKI 4
5 Identification of Patients at Risk for Acute Kidney Injury Is an Unmet Clinical Need Acute kidney injury (AKI) is prevalent in critically ill patients and has serious consequences. 1 High incidence (2.1/1000 population) 2,3 similar to that of acute myocardial infarction Increased risk of death or end-stage renal disease developing within at least one year following the index event 3,4 1. Uchino S, Kellum JA, Bellomo R et al. J Am Med Assoc. 2005;294(7): Ali T, Khan I, Simpson W et al. J Am Soc Nephrol. 2007;18(4): Kellum JA, Bellomo R, Ronco C. J Am Med Assoc. 2012;307(21) Amdur RL, Chawla LS, Amodeo S et al. Kidney Int. 2009;76(10):
6 Identification of Patients at Risk for Acute Kidney Injury Is an Unmet Clinical Need Early recognition and management of patients at risk for AKI is paramount since there are no specific therapies to reverse established AKI. 1 As compared to myocardial infarction, AKI may not provide early signs and symptoms sufficient to guide risk assessment. 2 Current methods for risk assessment are insufficient, placing substantial numbers of patients at serious risk of death and morbidity. 1,2 1. KDIGO Clinical Practice Guideline. Kidney Inter. Suppl. 2012;2: MacLeod A. Lancet. 2009;374:
7 II. The NEPHROCHECK Test System 7
8 The NEPHROCHECK Test The NEPHROCHECK Test should not be used as a standalone test and results have only been validated in patients who currently have or have had within the past 24 hours acute cardiovascular and or respiratory compromise and are ICU patients. Test results should be evaluated in the context of all clinical and laboratory data available. In those instances where the NEPHROCHECK Test results do not agree with the clinical evaluation, clinical judgment and additional tests should be used accordingly. 8
9 The NEPHROCHECK Test System Components 9
10 The NEPHROCHECK Test System Components Materials Provided The NEPHROCHECK Test Kit contains all the reagents needed for the generation of NEPHROCHECK Test results in human adult urine specimens. The NEPHROCHECK Test Kit (Part Number ) contains: NEPHROCHECK Test NEPHROCHECK Test Conjugate Vial NEPHROCHECK Test RFID Card... 1 NEPHROCHECK Test Buffer (2 x 5 ml)... 1 NEPHROCHECK Test Kit Package Insert... 1 Materials Required But Not Provided ASTUTE140 Meter Kit (PN ) NEPHROCHECK Liquid Control Kit (PN ) NEPHROCHECK Calibration Verification Kit (PN ) NEPHROCHECK Electronic Quality Control (PN ) Calibrated precision pipette, capable of dispensing 100 µl 10
11 The NEPHROCHECK Test Warnings and Precautions The NEPHROCHECK Test is not for Point-of-Care Use 11
12 Principle of the NEPHROCHECK Test: Fluorometric Sandwich Immunoassay Single-use cartridge consists of a membrane test strip with proprietary reagents enclosed in a plastic housing that is precisely molded for reproducible and accurate results Membrane test strip has capture antibodies immobilized in discreet zones for quantitative detection of urinary biomarkers TIMP-2 and IGFBP-7, and for checking Test integrity Fluorescent antibody reagents are mixed with a patient s urine sample and are applied to the single-use cartridge 12
13 Performing the NEPHROCHECK Test Buffer Vial Step 1 Pipette 100 µl of buffer into conjugate vial Step 3 Pipette 100 µl of mixed sample into cartridge Step 4 Place cartridge in meter Step 5 20 minutes to results Conjugate Vial Step 2 Pipette 100 µl of centrifuged urine into conjugate vial Urine Specimen Cup Each lot of the NEPHROCHECK Test cartridges and the ASTUTE140 Meter is calibrated at the factory no need for user calibration Lot-specific information such as assay calibration curves and expiration date are loaded into the ASTUTE140 Meter from the RFID card. 13
14 Quality Control Considerations The NEPHROCHECK Test System incorporates several methods for Quality Control, including the NEPHROCHECK Test Liquid Controls, the NEPHROCHECK Test Calibration Verification (Cal Vers) Materials and the ASTUTE140 Electronic Quality Control (EQC Device). Good Laboratory Practice suggests: NEPHROCHECK Test Liquid Controls should be tested: Every 30 days With each new lot number of NEPHROCHECK Test Kits With each new shipment of the NEPHROCHECK Test Kits After ASTUTE140 Meter maintenance or servicing In accordance with your local, state, and/or federal regulations or accreditation requirements and standard quality control procedures NEPHROCHECK Test Calibration Verification Materials should be tested: At least once every 6 months After ASTUTE140 Meter maintenance or servicing In accordance with local, state, and/or federal regulations or accreditation requirements. ASTUTE140 Electronic Quality Control (EQC) Device be tested: Daily After ASTUTE140 Meter maintenance or servicing In accordance with your local, state, and/or federal regulations or accreditation requirements 14
15 The NEPHROCHECK Test Results The ASTUTE140 Meter automatically calculates and displays a single numerical test result (AKIRISK Score) derived from the measurement of TIMP-2 and IGFBP-7. The AKIRISK Score is displayed on the ASTUTE140 Meter screen without units after the NEPHROCHECK Test procedure is completed. Results for the individual markers are not displayed. The numerical AKIRISK Score is calculated by multiplying the concentrations of the two biomarkers, and then dividing by 1000: The NEPHROCHECK Test Result (AKIRISK Score) = [TIMP-2]*[IGFBP-7] (units = (ng/ml) 2 /1000)
16 III. Clinical Performance 16
17 The NEPHROCHECK Test Was Validated in Two Clinical Studies in the Intended Use Population 23 sites in the US Age 21, Intended Use population*, Within ± 24 hrs of ICU admission N = 408 Urine sample collected at enrollment No AKI N = 337 Study A Diagnosis of AKI or No AKI within 12 hours after enrollment as determined by an adjudication committee AKI N = 71 * Intended Use Population: patients who currently have or have had within the past 24 hours acute cardiovascular and or respiratory compromise and are ICU patients Patient status within the 12 hours after enrollment Study B 6 sites in the US Age 21Intended Use population*, Within ± 24 hrs of ICU admission N = 126 Urine sample collected at enrollment Diagnosis of AKI or No AKI within 12 hours after enrollment as determined by an adjudication committee Patient status within the 12 hours after enrollment No AKI AKI N = 97 N = 29 NEPHROCHECK Test measurement of urine samples NEPHROCHECK Test measurement of urine samples 17
18 The 408 Intended Use Patients Were Stratified into Two Groups by AKIRisk Score (Study A) Negative AKIRisk Score ( 0.3) 163 Intended Use Patients Positive AKIRisk Score (> 0.3) 245 Intended Use Patients 6 patients had AKI 157 patients didn t have AKI = AKI = No AKI Patient status within the 12 hours after enrollment 65 patients had AKI 180 patients didn t have AKI 18
19 The 126 Intended Use Patients Were Stratified into Two Groups by AKIRISK Score (Study B) Negative AKIRisk Score ( 0.3) 56 Intended Use Patients Positive AKIRisk Score (> 0.3) 70 Intended Use Patients k 7 patients had AKI 49 patients didn t have AKI 22 patients had AKI 48 patients didn t have AKI = AKI = No AKI Patient status within the 12 hours after enrollment 19
20 How Do NEPHROCHECK Test Results Relate to Negative and Positive Predictive Values (NPV and PPV) for the Cutoff > 0.3 in Intended Use Patients? (Study A) Negative AKIRisk Score ( 0.3) 163 Intended Use Patients Positive AKIRisk Score (> 0.3) 245 Intended Use Patients NPV: proportion of Intended Use patients with Negative AKIRISK Score 0.3 who did not have AKI PPV: proportion of Intended Use patients with Positive AKIRISK Score > 0.3 who had AKI NPV = 157 ( No AKI patients with AKIRISK Score 0.3) 163 (all patients with AKIRISK Score 0.3) NPV = 96% X 100% 96% of Intended Use patients with a Negative AKIRisk Score ( 0.3) did not manifest moderate to severe AKI within 12h. PPV = 65 ( AKI patients with AKIRISK Score > 0.3) 245 (all patients with AKIRISK Score > 0.3) PPV = 27% 27% (1 out of 4) of Intended Use patients with a Positive AKIRisk Score (> 0.3) manifested moderate to severe AKI within 12h. 20 X 100
21 How Do NEPHROCHECK Test Results Relate to Negative and Positive Predictive Values (NPV and PPV) for the Cutoff > 0.3 in Intended Use Patients? (Study B) Negative AKIRisk Score ( 0.3) 56 Intended Use Patients Positive AKIRisk Score (> 0.3) 70 Intended Use Patients k NPV: proportion of Intended Use patients with a Negative AKIRISK Score 0.3 who did not have AKI PPV: proportion of Intended Use patients with a Positive AKIRISK Score > 0.3 who had AKI NPV = 49( No AKI patients with AKIRISK Score 0.3) 56 (all patients with AKIRISK Score 0.3) NPV = 88% X 100% 88% of Intended Use patients with a Negative AKIRisk Score ( 0.3) did not manifest moderate to severe AKI within 12h. PPV = 22 ( AKI patients with AKIRISK Score > 0.3) 70 (all patients with AKIRISK Score > 0.3) PPV = 31% X % (1 out of 3) of Intended Use patients with a positive AKIRisk Score (> 0.3) manifested moderate to severe AKI within 12h. 21
22 Clinical Performance was Evaluated in Two Studies: A and B 90 th Percentile 75 th Percentile Median 25 th Percentile 10 th Percentile The AKIRISK Score was not statistically different between studies A and B (p > 0.05 for No AKI subjects and for AKI subjects). For subjects with AKI, variability in the AKIRISK Score (indicated by the interquartile range (Central 95%)) in Study B was larger than in Study A and was associated with a lower sensitivity in Study B (0.76, 95% CI ) compared with Study A (0.92, 95% CI ). 22
23 Comparison of AKIRISK Score with Diagnosis of AKI or No AKI (Study A and B) Study A Laboratory 1 AKIRISK Score > 0.3 AKIRISK Score 0.3 Total Number of Test Results AKI 65 (16.0%) TP 6 (1.5%) FN No AKI 182 (44.7%) FP 154 (37.8%) TN Total Number of Test Results* Study A Laboratory 2 AKIRISK Score > 0.3 AKIRISK Score 0.3 Total Number of Test Results AKI 64 (15.7%) TP 7 (1.7%) FN No AKI 172 (42.3%) FP 164 (40.3%) TN Total Number of Test Results* Study A Laboratory 3 AKIRISK Score > 0.3 AKIRISK Score 0.3 Total Number of Test Results AKI 66 (16.2%) TP 5 (1.2%) FN No AKI 186 (45.7%) FP 150 (36.9%) TN Total Number of Test Results* Study B AKI No AKI AKIRISK Score > 0.3 AKIRISK Score 0.3 Total Number of Test Results 22 (17.5%) TP 7 (5.6%) FN 48 (38.1%) FP 49 (38.9%) TN Total Number of Test Results TP = True Positive, FP = False Positive, FN = False Negative, TN = True Negative AKI prevalence was 17% in Study A and 23% in Study B * In Study A, test results from 407 of 408 enrolled patients are reported from each laboratory, because each laboratory had one missing test result. The missing test result was from a different patient at each laboratory (altogether, 3 patients were missing a test result from one laboratory but had test results from the other two laboratories, and 405 patients had test results from all three laboratories). 23
24 IV. Interpreting the NEPHROCHECK Test Results 24
25 The NEPHROCHECK Test Intended Use and Indications The Astute Medical NEPHROCHECK Test System is intended to be used in conjunction with clinical evaluation in patients who currently have or have had within the past 24 hours acute cardiovascular and or respiratory compromise and are ICU patients as an aid in the risk assessment for moderate or severe acute kidney injury (AKI) within 12 hours of patient assessment. The NEPHROCHECK Test System is intended to be used in patients 21 years of age or older. 25
26 The NEPHROCHECK Test Reportable Range and Reference Ranges Result Reportable Range* AKIRISK Score * * AKIRISK Scores that are outside the above reportable range are reported as either < 0.04 or > by the ASTUTE140 Meter. If the AKIRISK Score is > 10.00, the specimen should not be diluted for retesting. Cohort Gender Number of Subjects AKIRISK Score Range Apparently Healthy subjects Subjects with stable chronic morbidities Intended Use subjects with No AKI (Study A) Intended Use subjects with AKI (Study A) All All All All Based on central 95% 26
27 Distribution of the NEPHROCHECK Test Results by Cohort (Study A) 7 Laboratory 1 Laboratory 2 Laboratory th Percentile AKIRISK Score N = 378 N = 372 N = 336 N = 71 N = 336 N = 71 N = 336 N = th Percentile Median 25 th Percentile 10 th Percentile Apparently healthy subjects Subjects with chronic stable morbidities No AKI AKI No AKI AKI No AKI Intended Use Subjects AKI AKIRISK Scores are not elevated (relative to results for apparently healthy subjects) for subjects with chronic comorbidities or for subjects representative of the intended use population without AKI. Conversely, AKIRISK Scores are substantially elevated for subjects representative of the intended use population with AKI. Because there is overlap between the distributions of the AKIRISK Scores for No AKI and AKI, NEPHROCHECK Test results cannot be used as standalone results, and, based on the low PPV, a result > 0.3 is not necessarily predictive of developing moderate to severe AKI within a specific time frame. 27
28 NEPHROCHECK Test Operating Characteristics for the Cutoff of > 0.3 for Moderate to Severe AKI Within 12 Hours of Patient Assessment for Risk of AKI (Studies A and B) Statistic Sensitivity (TPR) Study A N = 408 (95% CI) 0.92 (0.85, 0.98) Study B N = 126 (95% CI) 0.76 (0.60, 0.91) FNR (1- Sensitivity) 0.08 (0.02, 0.15) 0.24 (0.09, 0.40) Sensitivity (equivalent to true positive rate or TPR): the AKIRISK Score was positive (> 0.3) for 76-92% of the patients of the intended use population who manifested moderate to severe AKI within 12 hours of patient assessment for risk of moderate to severe AKI. Thus, the NEPHROCHECK Test captured the majority (76-92%) of the AKI cases. False negative rate (FNR; equivalent to 1-sensitivity): the AKIRISK Score was negative ( 0.3) for 8-24% of the patients who manifested moderate to severe AKI within 12 hours of patient assessment for risk of moderate to severe AKI. Thus, for a negative AKIRISK Score ( 0.3), the clinician should consider all clinical information and manage the patient according to standard of care. 28
29 NEPHROCHECK Test Operating Characteristics for the Cutoff of > 0.3 for Moderate to Severe AKI Within 12 Hours of Patient Assessment for Risk of AKI (Studies A and B) Statistic Specificity (TNR) Study A N = 408 (95% CI) 0.46 (0.41, 0.52) Study B N = 126 (95% CI) 0.51 (0.41, 0.60) FPR (1- Specificity) 0.54 (0.48, 0.59) 0.49 (0.40, 0.59) Specificity (equivalent to true negative rate or TNR): the AKIRISK Score was negative (< 0.3) for 46%-51% of the patients in the intended use population who did not manifest moderate to severe AKI within 12 hours of patient assessment for risk of moderate to severe AKI. False positive rate (FPR; equivalent to 1 specificity): the AKIRISK Score was positive (> 0.3) for 49%-54% of the patients (approximately 1 out of every 2 patients) who did not manifest moderate to severe AKI within 12 hours of patient assessment for risk of moderate to severe AKI. Therefore a positive AKIRISK Score of (> 0.3) must be evaluated with other clinical and laboratory findings and may not be predictive of developing AKI within 12 hours of patient assessment. 29
30 Understanding the NEPHROCHECK Test Results In Intended Use Patients Based on the PPV of 27 (Study A) 31 (Study B)%, a positive AKIRISK Score (> 0.3) is not necessarily predictive of developing moderate to severe AKI within a specific time frame. The patient might not develop moderate to severe AKI within 12 hours of evaluation. NEPHROCHECK Test Result What It Means Positive AKIRISK Score (> 0.3) Patient could develop moderate to severe AKI within 12 hours of evaluation. Negative AKIRISK Score ( 0.3) Patient might not develop moderate to severe AKI within 12 hours of evaluation. Based upon results from clinical testing, patients in the intended use population with negative AKIRISK TM Scores (< 0.3) are at lower risk of developing moderate to severe AKI within 12 h of assessment than patients in the intended use population with positive AKIRISK TM Scores (> 0.3). 30
31 V. Limitations of the NEPHROCHECK Test 31
32 Limitations of the NEPHROCHECK Test Result The NEPHROCHECK Test should not be used as a standalone test. Results have only been validated in patients who currently have or have had within the past 24 hours acute cardiovascular and or respiratory compromise and are ICU patients. An AKIRISK Score > 0.3 may not be indicative of developing moderate to severe AKI within 12 hours of sampling. All NEPHROCHECK Test results should be evaluated in the context of all clinical and laboratory data available. In those instances where NEPHROCHECK Test results do not agree with clinical evaluation, clinical judgment and additional tests should be used accordingly. In addition, not all patients who manifest AKI will test positive on the NEPHROCHECK Test, and some patients who test positive will not manifest AKI. The AKIRISK Score is intended to be used in conjunction with clinical evaluation as an adjunct to standard of care. 32
33 Limitations of the NEPHROCHECK Test Result The following substances exhibited significant interference (exhibited a bias exceeding 10%) with the AKIRISK Score as described below: Urinary albumin at concentrations above 125 mg/dl interfere with the NEPHROCHECK Test results. Urinary albumin at concentrations above 3000 mg/dl cause an invalid test result. Urinary bilirubin at concentrations above 7.2 mg/dl interfere with the NEPHROCHECK Test results. Use caution in interpreting NEPHROCHECK Test results in patients with significant proteinuria or severe hyperbilirubinuria. Methylene blue at concentrations above 0.49 mg/l interferes with NEPHROCHECK Test results. 33
34 Limitations of the NEPHROCHECK Test Result Variability in the AKIRISK Score has been observed in normal populations and by race. A wide range in the values of AKIRISK Scores was observed in apparently healthy subjects and subjects with stable chronic morbidities and the range of observed values of AKIRISK Scores was wider for Caucasians than for non-caucasians for each cohort (apparently healthy subjects; subjects with stable chronic morbidities; and patients in the intended use population). Although greater variability in the AKIRISK Scores was observed with Caucasian subjects than for non-caucasians, logistic covariate analysis demonstrated that race (Caucasian, non-caucasian) did not have a statistically significant main effect, whereas the NEPHROCHECK Test was highly significant (p < ); therefore the NEPHROCHECK Test performance is robust with respect to race. 34
35 VI. Training Program and Support 35
36 The NEPHROCHECK Test System Training Program Materials NEPHROCHECK Test System Training Program PowerPoint slide presentation Supplemental training materials include copies of the: NEPHROCHECK Test Instructions for Use NEPHROCHECK Liquid Controls Kit Instructions for Use; NEPHROCHECK Calibration Verification (Cal Vers) Kit Instructions for Use ASTUTE140 Meter Manual, and NEPHROCHECK Proficiency Test. 36
37 Identification of Trainees Potential personnel to receive training: Potential Department(s) Role Possible Job Titles critical care physicians Intensive Care Unit(s) Personnel ordering the test interpreting/using the test results nephrologists intensivists residents cardio-thoracic surgeons Medical Floor Personnel Emergency Department Personnel ordering the test interpreting/using the test results ordering the test interpreting/using the test results anesthesiologists hospitalists physicians residents physicians residents Laboratory running the test laboratory professionals 37
38 How to Request Additional Training To request additional training for new employees or additional potential users of the Astute NEPHROCHECK Test System, please contact: Your Astute Medical Trainer, Your Astute Sales Representative, or Astute Medical s Customer Support Team Astute Medical, Inc General Atomics Court Building 2 San Diego, CA USA Phone: +1 (855) Fax: +1 (858) customerservice@astutemedical.com technicalsupport@astutemedical.com 38
39 How to Access Training Materials To access the NEPHROCHECK Test Training Materials on the web, go to Materials are password protected Password may be obtained by contacting your Astute Medical Trainer or Astute Medical s Customer Support Team Copies of Training Materials are also available by request through your Astute Medical Trainer, Astute Medical Sales Representative or Astute Medical s Customer Support Team Trainings may be scheduled during weekends and across shifts (e.g., evenings, nights and early mornings) On-site and web-conferenced based trainings are available 39
40 Customer Service and Technical Support For questions regarding the use or performance of the NEPHROCHECK Test Kit or any Astute Medical, Inc. product, please contact Astute Technical Support. Astute Medical, Inc General Atomics Court Building 2 San Diego, CA USA Phone: +1 (855) Fax: +1 (858) customerservice@astutemedical.com technicalsupport@astutemedical.com Slides will be posted on the Astute Medical education page: 40
NEPHROCHECK Calibration Verification Kit Package Insert
NEPHROCHECK Calibration Verification Kit Package Insert Manufactured for Astute Medical, Inc. 3550 General Atomics Ct. Building 2 San Diego, CA 92121 USA Intended Use The NEPHROCHECK Calibration Verification
More informationNEPHROCHECK Liquid Control Kit Package Insert
NEPHROCHECK Liquid Control Kit Package Insert Manufactured for Astute Medical, Inc. 3550 General Atomics Ct. Building 2 San Diego, CA 92121 USA Intended Use The NEPHROCHECK Liquid Controls are used for
More informationNEPHROCHECK Liquid Control Kit Package Insert
NEPHROCHECK Liquid Control Kit Package Insert Manufactured for Astute Medical, Inc. 3550 General Atomics Ct. Building 2 San Diego, CA 92121 USA Intended Use The NEPHROCHECK Liquid Controls are used for
More informationMDSS GmbH Schiffgraben Hannover Germany
NEPHROCHECK Test Kit Package Insert 1 NEPHROCHECK Test Kit Package Insert For Export Only. Not for Sale in the United States. Manufactured for Astute Medical, Inc. 3550 General Atomics Ct. Building 2 San
More informationNEPHROCHECK Test Kit Package Insert
NEPHROCHECK Test Kit Package Insert Manufactured for Astute Medical, Inc. 3550 General Atomics Ct. Building 2 San Diego, CA 92121 USA Intended Use The Astute Medical NEPHROCHECK Test System is intended
More information25 OH Vitamin D Rapid test
INSTRUCTION FOR USE REF:GDB 7120-25T 25 OH Vitamin D Rapid test Rapid Whole Blood Vitamin D Test A Rapid Sandwich Immunochromatographic Test for the Quantitative Detection of total 25-OH Vitamin D in human
More informationMouse C-Peptide ELISA Kit
Mouse C-Peptide ELISA Kit Cat.No: DEIA4507 Lot. No. (See product label) Size 96T Intended Use The Mouse C-Peptide ELISA kit is for the quantitative determination of c-peptide in mouse serum, plasma, and
More informationINSTANT-VIEW H. pylori Rapid Test CLIA WAIVED Test for Whole Blood QUALITATIVE IN-VITRO DIAGNOSTIC TEST FOR EXTERNAL USE ONLY
INTENDED USE INSTANT-VIEW H. pylori Rapid Test CLIA WAIVED Test for Whole Blood QUALITATIVE IN-VITRO DIAGNOSTIC TEST FOR EXTERNAL USE ONLY INSTANT-VIEW H. pylori Rapid Test is a rapid qualitative immunoassay
More informationHuman HIV (1+2) antigen&antibody ELISA Kit
Human HIV (1+2) antigen&antibody ELISA Kit Catalog Number. CSB-E18042h For the qualitative determination of human HIV (1+2) antibody and P24 antigen concentrations in serum, plasma. This package insert
More informationHbA1c (Human) ELISA Kit
HbA1c (Human) ELISA Kit Cat. No.:DEIA3509 Pkg.Size:96T Intended use GHbA1c (Human) ELISA Kit is a sandwich enzyme immunoassay for the quantitative measurement of human GHbA1c. General Description vhemoglobin,
More informationUrea Nitrogen (BUN) detection Kit
K-ASSAY KAMIYA BIOMEDICAL COMPANY KAMIYA BIOMEDICAL COMPANY Urea Nitrogen (BUN) detection Kit For the quantitative determination of urea nitrogen in saliva and TCM Cat. No. KT-747 For Research Use Only.
More informationThe NGAL Turbidimetric Immunoassay Reagent Kit
Antibody and Immunoassay Services Li Ka Shing Faculty of Medicine, University of Hong Kong The NGAL Turbidimetric Immunoassay Reagent Kit Catalogue number: 51300 For the quantitative determination of NGAL
More informationChymotrypsin ELISA Kit
Chymotrypsin ELISA Kit Cat. No.:DEIA10041 Pkg.Size:96T Intended use The Chymotrypsin ELISA Kit is a sandwich Enzyme Immuno Assay intended for the quantitative determination of Chymotrypsin in stool. General
More informationHuman Cytomegalovirus IgM ELISA Kit
Human Cytomegalovirus IgM Catalog No: IRAPKT2012 ELISA Kit Lot No: SAMPLE INTENDED USE The CMV IgM ELISA is intended for use in the detection of IgM antibodies to Cytomegalovirus (CMV) infection in human
More informationSerum Amyloid A ELISA
Serum Amyloid A ELISA For the quantitative determination of serum amyloid A (SAA) in serum plasma For Research use Only. Not for Use in Diagnostic Procedures Please see Appendix A for Reference Serum information
More information25 OH Vitamin D Rapid Test
INSTRUCTION FOR USE REF:GDB 7120-25T 25 OH Vitamin D Rapid Test A Rapid Sandwich Immunochromatographic Test for Quantitative Detection of total 25-OH Vitamin D in human finger-prick blood For In Vitro
More informationHuman Cytomegalovirus Virus (CMV) IgG ELISA Kit
Human Cytomegalovirus Virus Catalog No: IRAPKT1410 (CMV) IgG ELISA Kit Lot No: SAMPLE INTENDED USE The CMV IgG ELISA is intended for use in evaluating a patient s serologic status to cytomegalovirus (CMV)
More informationHBsAg CONFIRMATORY TEST
HBsAg CONFIRMATORY TEST For the confirmation of positive samples with UMELISA HBsAg PLUS CLINICAL INTEREST After the discovery of Hepatitis B surface Antigen (HBsAg)(1), increasingly sensitive and specific
More informationDisclosures. Acute Kidney Injury. Outline. Do electronic alerts improve the care of patients with AKI? 5/9/2015
Disclosures Acute Kidney Injury Kathleen D. Liu, MD, PhD May 2015 Consultant: Achaogen, Chemocentryx, Durect, Z Pharma Clinical trials adjudication: Astute Funding: NIH Stockholder: Amgen Outline patients
More informationCYTOMEGALOVIRUS (CMV) IgM ELISA Kit Protocol
CYTOMEGALOVIRUS (CMV) IgM ELISA Kit Protocol (Cat. No.:EK-310-91) 330 Beach Road, Burlingame CA Tel: 650-558-8898 Fax: 650-558-1686 E-Mail: info@phoenixpeptide.com www.phoenixpeptide.com INTENDED USE The
More informationIntended use. Summary and explanation of test
NESPI-FRCT-001EN(V.0.1) Intended use The FREND Cardiac Triple test is a fluorescent nanoparticle immunoassay designed for in vitro quantitative measurement of myoglobin, troponin I, and creatine kinase
More informationInsulin (Porcine/Canine) ELISA
Insulin (Porcine/Canine) ELISA For the quantitative measurement of insulin in Porcine/Canine serum and plasma (EDTA) For Research Use Only. Not For Use In Diagnostic Procedures. Catalog Number: 80-INSPO-E01
More informationSee external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationBÜHLMANN fcal turbo. Calprotectin turbidimetric assay for professional use. Reagent Kit B-KCAL-RSET. Revision date:
BÜHLMANN fcal turbo Calprotectin turbidimetric assay for professional use Reagent Kit B-KCAL-RSET Revision date: 2017-02-24 BÜHLMANN LABORATORIES AG Baselstrasse 55 4124 Schönenbuch, Switzerland Tel.:
More informationApolipoprotein A-1 ELISA
Apolipoprotein A-1 ELISA For the quantitative determination of apolipoprotein A1 in serum and plasma. For Research Use Only. Not For Use In Diagnostic Procedures. Please read carefully due to Critical
More informationGSI Canine IL-5 ELISA Kit-2 Plates DataSheet
Interleukin5 (IL5) is a secreted glycoprotein that belongs to the α-helical group of cytokines (1, 2, 3). Unlike other family members, it is present as a covalently linked antiparallel dimer (4, 5). IL-5
More informationInstructions for use. TSH rat ELISA. Please use only the valid version of the Instructions for Use provided with the kit AR E-8600
Instructions for use TSH rat ELISA AR E-8600 TSH rat ELISA 1. INTRODUCTION 1.1 Intended use The TSH rat ELISA is an enzyme immunoassay for the quantitative measurement of TSH in rat serum. For research
More informationAccepted Manuscript. Looking to Prevent Acute Kidney Injury After Cardiac Surgery? Just Check the Urine.
Accepted Manuscript Looking to Prevent Acute Kidney Injury After Cardiac Surgery? Just Check the Urine. Daniel T. Engelman, MD, FACS, Michael J. Germain, MD PII: S0022-5223(18)32651-5 DOI: 10.1016/j.jtcvs.2018.08.119
More informationToxoplasma gondii IgM ELISA Kit
Toxoplasma gondii IgM ELISA Kit Catalog Number KA0226 96 assays Version: 01 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle
More informationRayBio Human Thyroglobulin ELISA Kit
RayBio Human Thyroglobulin ELISA Kit Catalog #: ELH-Thyroglobulin User Manual Last revised July 6, 2017 Caution: Extraordinarily useful information enclosed ISO 13485 Certified 3607 Parkway Lane, Suite
More informationAbraxis Progesterone (bovine) ELISA Kit
Abraxis Progesterone (bovine) ELISA Kit Enzyme immunoassay for the quantitative determination of progesterone in bovine milk/serum/plasma samples PN5081M 96 Tests For Research Use Only. Not for use in
More informationNGAL, a new markers for acute kidney injury
NGAL, a new markers for acute kidney injury Prof. J. Delanghe, MD, PhD Dept. Clinical Chemistry Ghent University Lecture Feb 8, 2011 Serum creatinine is an inadequate marker for AKI. > 50% of renal
More informationRapid-VIDITEST. Influenza A+B
Rapid-VIDITEST Influenza A+B (One step Influenza A+B blister Test for the detection of Influenza type A and type B from nasal swabs, nasal wash or nasal aspirate specimens). Instruction manual Producer:
More informationPolymer Technology Systems, Inc. CardioChek PA Comparison Study
Polymer Technology Systems, Inc. CardioChek PA Comparison Study Evaluation Protocol: Accuracy Precision Clinical Correlation PTS Panels Lipid Panel Test Strips For Use in Comparisons to a Reference Laboratory
More informationBlood Urea Nitrogen Detection Kit
Discovery through partnership Excellence through quality StressXpress Blood Urea Nitrogen Detection Kit Catalog# SKT-213 (2 Plate kit) Quantitative colorimetric measurement of urea nitrogen TABLE OF CONTENTS
More informationDIAGNOSTIC AUTOMATION, INC.
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationMorinaga Mouse C-peptide ELISA Kit
Morinaga Mouse C-peptide ELISA Kit For the quantitative determination of C-peptide in mouse serum, plasma, and fluid 96wells For Laboratory Use Only, not for use in diagnostic procedure Please read full
More informationSee external label 2 C-8 C 96 tests CHEMILUMINESCENCE. CMV IgG. Cat # Step (20-25 C Room temp.) Volume
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationRotavirus Test Kit. Instructions For Use. Format: Cassette Specimen: Fecal Extract Catalog Number: VEL-001-ROTA
Rotavirus Test Kit Instructions For Use Format: Cassette Specimen: Fecal Extract Catalog Number: VEL-001-ROTA * Please read the instructions carefully before use INTENDED USE Velotest Rotavirus Test is
More informationH.Pylori IgG
DIAGNOSTIC AUTOMATION, INC. 21250 Califa Street, Suite 102 and116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com
More informationRayBio Human Granzyme B ELISA Kit
RayBio Human Granzyme B ELISA Kit Catalog #: ELH-GZMB User Manual Last revised April 15, 2016 Caution: Extraordinarily useful information enclosed ISO 13485 Certified 3607 Parkway Lane, Suite 100 Norcross,
More informationBovine Insulin ELISA
Bovine Insulin ELISA For quantitative determination of insulin in bovine serum and plasma. For Research Use Only. Not For Use In Diagnostic Procedures. Catalog Number: 80-INSBO-E01 Size: 96 wells Version:
More informationH.Pylori IgG Cat # 1503Z
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationToxoplasma gondii IgM (Toxo IgM)
DIAGNOSTIC AUTOMATION, INC. 21250 Califa Street, Suite 102 and116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com
More informationHuman LDL ELISA Kit. Innovative Research, Inc.
Human LDL ELISA Kit Catalog No: IRKTAH2582 Lot No: SAMPLE INTRODUCTION Human low-density lipoprotein (LDL) transports cholesterol from the liver to tissues where it is incorporated into cell membranes.
More informationPorcine/Canine Insulin ELISA
Porcine/Canine Insulin ELISA For the quantitative determination of insulin in porcine or canine serum and plasma. Please read carefully due to Critical Changes, e.g., Calculation of Results. For Research
More informationDetectX. Urinary Creatinine Detection Kit. Catalog Number K002-H1. Sample Types Validated: Human, Monkey, Dog, Rat and Mouse Urine
World s Only One Component Assay Simple & Easy to Use DetectX Urinary Creatinine Detection Kit Catalog Number K002-H1 Sample Types Validated: Human, Monkey, Dog, Rat and Mouse Urine Please read this insert
More informationRayBio Human ENA-78 ELISA Kit
RayBio Human ENA-78 ELISA Kit Catalog #: ELH-ENA78 User Manual Last revised April 15, 2016 Caution: Extraordinarily useful information enclosed ISO 13485 Certified 3607 Parkway Lane, Suite 100 Norcross,
More informationAmantadine ELISA Test Kit
Amantadine ELISA Test Kit Catalog No. LSY-10052 1. Principle This test kit is based on the competitive enzyme immunoassay for the detection of Amantadine. The coupling antigen is pre-coated on the micro-well
More informationHuman Thyroid-Peroxidase Antibody, TPO-Ab ELISA Kit
Human Thyroid-Peroxidase Antibody, TPO-Ab ELISA Kit Catalog No: E0442h 96 Tests Operating instruction www.eiaab.com FOR RESEARCH USE ONLY; NOT FOR THERAPEUTIC OR DIAGNOSTIC APPLICATIONS! PLEASE READ THROUGH
More informationSmart Diagnostics for Point-of-Care!
Smart Diagnostics for Point-of-Care! The one special multi-parameter Point-of-Care (POC) instrument that covers the constantly expanding range of applications with the highest precision. Designed for HbA1c
More informationhuman Total Cathepsin B Catalog Number: DY2176
human Total Cathepsin B Catalog Number: DY2176 This DuoSet ELISA Development kit contains the basic components required for the development of sandwich ELISAs to measure natural and recombinant human Total
More informationGentian Canine CRP Immunoassay Application Note for Abbott Architect * c4000
v2-jan214 Gentian Canine CRP Immunoassay Application Note for Abbott Architect * c4 Intended Use The canine CRP immunoassay on Abbott's Architect c4 is an in vitro diagnostic test for quantitative determination
More informationSee external label 96 tests HSV 2 IgA. Cat #
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationRubella virus IgG ELISA Kit
Rubella virus IgG ELISA Kit Catalog Number KA0223 96 assays Version: 03 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of
More informationReferences Required document for Laboratory Accreditation by the College of American Pathologists.
Subject NT-proBNP Cobas e601 Index Number Lab-4011 Section Laboratory Subsection Chemistry Category Departmental Contact Benjamin Michel Last Revised 10/19/2016 References Required document for Laboratory
More informationToxoplasma gondii IgM ELISA Kit
Toxoplasma gondii IgM ELISA Kit Catalog Number KA0226 96 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle
More informationHuman Thyroglobulin EIA
Human Thyroglobulin EIA For the quantitative determination of human thyroglobulin (htg) in plasma and serum. For Research Use Only. Not For Use In Diagnostic Procedures. Catalog Number: 30-7510 Size: 96
More informationCreatinine Test Code: CRE
Creatinine Test Code: CRE Intended Use For in vitro diagnostic use only CARESIDE cartridges are used with the CARESIDE Analyzer to quantitatively measure creatinine concentration in anti-coagulated whole
More informationNori Rabbit IL-2 ELISA Kit DataSheet
Nori Rabbit IL-2 ELISA Kit DataSheet IL-2 is an interleukin, a type of cytokine immune system signaling molecule. IL-2 is a T cell stimulatory cytokine best known for inducing T cell proliferation, the
More informationMouse C3 (Complement Factor 3) ELISA Kit
Mouse C3 (Complement Factor 3) ELISA Kit Cat. No.:DEIA8289 Pkg.Size:96T Intended use The Mouse C3 (Complement Factor 3) ELISA Kit is a highly sensitive two-site enzyme linked immunoassay (ELISA) for measuring
More informationEstrone EIA kit. For the quantitative determination of estrone in dried fecal extracts, urine and tissue culture media. Cat. No.
K-ASSAY KAMIYA BIOMEDICAL COMPANY KAMIYA BIOMEDICAL COMPANY Estrone EIA kit For the quantitative determination of estrone in dried fecal extracts, urine and tissue culture media Cat. No. KT-720 For Research
More informationWHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: DPP HIV 1/2 Assay WHO reference number: PQDx
WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT Product: DPP HIV 1/2 Assay WHO reference number: PQDx 0053-006-00 DPP HIV 1/2 Assay with product code 65-9506-0, manufactured by Chembio Diagnostic
More informationIgG Antibodies To Toxoplasma Gondii ELISA Kit Protocol
IgG Antibodies To Toxoplasma Gondii ELISA Kit Protocol (Cat. No.:EK-310-85) 330 Beach Road, Burlingame CA Tel: 650-558-8898 Fax: 650-558-1686 E-Mail: info@phoenixpeptide.com www.phoenixpeptide.com INTENDED
More informationT R A I N I N G G U I D E
TRAINING GUIDE InstaCube Oral Fluid Drug Test For Forensic Use Only Powered By: Contents 3 The information in this presentation is a general overview on performing and interpreting the InstaCube Oral Fluid
More informationProduct Information. Instruction for Use. Troponin I ELISA kit Catalog Number: EA Storage Temperature: 2 8 C
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 Phone: 1.888.267.4436 Fax: 301-340-9254 Email: techsupport@origene.com Web: www.origene.com Product Information Troponin I ELISA kit Catalog Number:
More informationQUICK REFERENCE INSTRUCTIONS
QUICK REFERENCE INSTRUCTIONS For use with the Sofia Analyzer only. CLIA Complexity: WAIVED Nasal Swab and Nasopharyngeal Swab specimens ONLY. Study the Package Insert and User Manual thoroughly before
More informationIVD Revised 22 July, 2008
INTENDED USE The DRG One Step HCG Pregnancy Test is an in vitro diagnostic test for the qualitative detection of human chorionic gonadotropin (hcg) in urine. The test is a two-site immunoassay employing
More informationNEPHROCHECK Calibration Verification Kit Package Insert
NEPHROCHECK Verifiation Kit Pakage Insert Manufatured for Astute Medial, In. 3550 General Atomis Ct. Building 2 San Diego, CA 92121 USA Intended Use The NEPHROCHECK Verifiation (Cal Vers) Materials are
More informationCanine Thyroid Stimulating Hormone, TSH ELISA Kit
Canine Thyroid Stimulating Hormone, TSH ELISA Kit Catalog No: E0463c 96 Tests Operating instruction www.eiaab.com FOR RESEARCH USE ONLY; NOT FOR THERAPEUTIC OR DIAGNOSTIC APPLICATIONS! PLEASE READ THROUGH
More informationIV2-113E Use by. Invitron Glargine ELISA Kit REF LOT IVD. Definitions. English. For in-vitro diagnostic use. Instructions for use.
Definitions Instructions for use REF Catalogue number IV2-113E Use by English Invitron Glargine ELISA Kit For in-vitro diagnostic use Σ 96 LOT IVD Lot/Batch Code Storage temperature limitations In vitro
More informationHuman Influenza A (Swine Flu) Rapid test
Human Influenza A (Swine Flu) Rapid test Cat.No: DTSXY-Z9 Lot. No. (See product label) Size 20T Intended use The Influenza A (Swine Flu) test is a rapid chromatographic immunoassay for the qualitative
More informationThyroid Stimulating Hormone (S-TSH) Thyroid Stimulating
ab108659 Thyroid Stimulating Hormone (S-TSH) Human ELISA Kit Instructions for Use For the quantitative measurement of Human Thyroid Stimulating Hormone (S-TSH) concentrations in serum. This product is
More informationRat Insulin ELISA. For the quantitative determination of insulin in rat serum and plasma. For Research Use Only. Not For Use In Diagnostic Procedures.
Rat Insulin ELISA For the quantitative determination of insulin in rat serum and plasma For Research Use Only. Not For Use In Diagnostic Procedures. Catalog Number: Size: 80-INSRT-E01, E10 96 wells, 10
More informationRayBio Phenylalanine Fluorometric Assay Kit
RayBio Phenylalanine Fluorometric Assay Kit User Manual Version 1.0 June 25, 2014 RayBio Phenylalanine Fluorometric (Cat#: 68-Phenyl-S100) RayBiotech, Inc. We Provide You With Excellent Support And Service
More informationHBeAg and HBeAg Ab ELISA Kit
HBeAg and HBeAg Ab ELISA Kit Catalog Number KA0290 96 assays Version: 17 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Principle of the Assay... 3
More informationS4. Summary of the GALNS assay validation. Intra-assay variation (within-run precision)
S4. Summary of the GALNS assay validation (i.) Intra-assay variation (within-run precision) Intra-assay variation was determined by measuring standard blood samples (low activity standard; medium activity
More informationQUICK REFERENCE INSTRUCTIONS For use with Sofia only.
QUICK REFERENCE INSTRUCTIONS For use with Sofia only. CLIA Complexity: Waived Study the Package Insert and User Manual thoroughly before using Quick Reference Instructions. This is not a complete Package
More informationRubella Latex Agglutination Test
Rubella Latex Agglutination Test Cat. No.:DLAT1088 Pkg.Size:30T Intended use The Rubella Latex Agglutination Test is a rapid latex particle agglutination test for the qualitative and semi-quantitative
More informationHerpes Simplex Virus 2 IgM HSV 2 IgM
DIAGNOSTIC AUTOMATION, INC. 21250 Califa Street, Suite 102 and 116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com
More informationQUICK REFERENCE INSTRUCTIONS For use with Sofia and Sofia 2. Rx only
QUICK REFERENCE INSTRUCTIONS For use with Sofia and Sofia 2. Rx only Test Procedure Study the Package Insert and User Manual thoroughly before using Quick Reference Instructions. This is not a complete
More informationAgenda. 15 Dec
Implementing Traceability for Heterogeneous Analytes An Industry View JCTLM Symposium on Reference Measurement Systems for Biologicals, December 15, 2004 R. Miller 15 Dec. 2004 1 Agenda Recent trends in
More informationRapid Detection FAQs
Rapid Detection FAQs 3M Rapid Detection Reader What are the dimensions of the Rapid Detection Reader? The Rapid Detection Reader includes the Control Module and the Test Module. The Control Module is 185
More informationLDL (Human) ELISA Kit
LDL (Human) ELISA Kit Cat. No.:DEIA3864 Pkg.Size:96T Intended use This immunoassay kit allows for the specific measurement of human low density lipoprotein, LDL concentrations in cell culture supernates,
More informationHuman Thyroid Stimulating Hormone CLIA kit
Human Thyroid Stimulating Hormone CLIA kit Cat. No.:DEEL0223 Pkg.Size:96 tests Intended use For the direct quantitative determination of Thyroid Stimulating Hormone in human serum by chemiluminescence
More informationWHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: INSTI HIV-1/HIV-2 Antibody Test Number: PQDx
WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: INSTI HIV-1/HIV-2 Antibody Test Number: PQDx 0002-002-00 Abstract INSTI HIV-1/HIV-2 Antibody Test with product codes, 90-1013, 90-1010,
More informationProthrombin (Human) ELISA Kit
Prothrombin (Human) ELISA Kit Catalog Number KA0496 96 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 Principle of the Assay... 3 General
More informationELEGANCE Chlamydia pneumoniae IgG ELISA KIT
INTENDED USE The ELEGANCE Chlamydia pneumoniae IgG ELISA has been designed for the in vitro diagnostic measurement of anti- Chlamydia pneumoniae IgG in the screening of human serum. PRINCIPLES OF THE ELEGANCE
More informationUrinary Collagen IV EIA
Urinary Collagen IV EIA Enzyme Immunoassay Instructions for Use FOR RESEARCH USE ONLY Not for use in Diagnostic Procedures ACTIF 3-27-3 Kyodo, Setagaya-ku, Tokyo 1560052 JAPAN TEL&FAX: +81(0)3-6413-1860
More informationAIA-600II Assay Specifications TgAb Test Code 048
AIA-600II Assay Specifications TgAb Test Code 048 Screen Item Data Screen 1 Lot ***Enter current cal. lot no. Cal 1 0 IU/mL Cal 2 2 IU/mL (example) Cal 3 4 IU/mL (example) Cal 4 10 IU/mL (example) Cal
More informationHEMOCHRON. Whole Blood Coagulation Systems
HEMOCHRON Whole Blood Coagulation Systems Citrated Activated Partial Thromboplastin Time (APTT) Cuvette Correlation Protocol for HEMOCHRON Microcoagulation Instruments MSIG:131 10/06 Dear Medical Professional:
More informationHuman TSH ELISA Kit. User Manual
Human TSH ELISA Kit User Manual Catalog number: GTX15585 GeneTex Table of Contents A. Product Description... 2 B. Kit Components... 3 C. Additional Required Materials (not included)... 3 D. Reagent Preparation...
More informationQuantitative Measurement of Emergency Biomarkers in Parallel
Point-of-Care Immunoassay Analyzer Quantitative Measurement of Emergency Biomarkers in Parallel Troponin I, Myoglobin, CK-MB, D-Dimer, NTproBNP, hscrp Results in 17 minutes Direct measurement from whole
More informationHIV-1 p24 ELISA Kit. Cat.No: DEIA10155 Lot. No. (See product label) Size. Storage. Principle Of The Test. Reagents And Materials Provided
HIV-1 p24 ELISA Kit Cat.No: DEIA10155 Lot. No. (See product label) Size 96T Storage All reagents should be stored at 2-8 C, and should not be used beyond the expiration date on the label. Once opened,
More informationWHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Uni-Gold HIV Number: PQDx Abstract
WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: Uni-Gold HIV Number: PQDx 0149-052-00 Abstract Uni-Gold HIV with product codes 1206502, 1206502N, 1206502E, 1206502N-100 manufactured
More informationHuman HBcAb IgM ELISA kit
Human HBcAb IgM ELISA kit Catalog number: NR-R10163 (96 wells) The kit is designed to qualitatively detect HBcAb IgM in human serum or plasma. FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC PURPOSES
More informationCDIA TM Rubella IgG/IgM Rapid Test Kit
CDIA TM Rubella IgG/IgM Rapid Test Kit Cat.No: DTSJZ024 Lot. No. (See product label) Intended Use The CDIA TM Rubella IgG/IgM Rapid Test Kit is a rapid chromatographic immunoassay for the qualitative detection
More informationAspartate Aminotransferase Test Code: AST
Aspartate Aminotransferase Test Code: AST Intended Use For in vitro diagnostic use only CARESIDE Aspartate Aminotransferase (AST) cartridges are used with the CARESIDE Analyzer to quantitatively measure
More informationInstructions for use. TSH rat ELISA. Please use only the valid version of the Instructions for Use provided with the kit AR E-8600
Instructions for use TSH rat ELISA AR E8600 TSH rat ELISA INTRODUCTION INTENDED USE The TSH rat ELISA is an enzyme immunoassay for the quantitative measurement of TSH in rat serum. For research use only.
More informationMouse GLP-2 EIA. Cat. No. KT-374. For the quantitative determination of GLP-2 in mouse serum or plasma. For Research Use Only. 1 Rev.
Mouse GLP-2 EIA For the quantitative determination of GLP-2 in mouse serum or plasma. Cat. No. KT-374 For Research Use Only. 1 Rev. 11357374 PRODUCT INFORMATION Mouse GLP-2 EIA Cat. No. KT-374 INTENDED
More information